Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 K33 K33 Apr 25, 2025 0.04 +0.50   
 KABE Group B KABEB Apr 25, 2025 249.95 +0.16   
 Kakel Max KAKEL Apr 25, 2025 9.40 -1.05   
 Kallebäck Property Invest KAPIAB Apr 25, 2025 190.00 +0.26   
 Kambi Group KAMBI Apr 25, 2025 118.10 0.00   
 Kancera KAN Apr 25, 2025 1.18 -3.60   
 Karnell Group AB (publ) KARNELB Apr 25, 2025 45.40 +6.95   
 Karnov Group KAR Apr 25, 2025 88.30 -1.01   
 Karolinska Development B KDEV Apr 25, 2025 0.92 +2.00   
 Katalysen Ventures AB KAV Apr 25, 2025 10.30 -4.63   
 KB Components KBC Apr 25, 2025 50.30 +0.90   
 KebNi B KEBNIB Apr 25, 2025 1.38 +7.12   
 Kentima Holding B KENH Apr 25, 2025 2.02 -1.94   
 Kiliaro KILI Apr 25, 2025 0.15 -22.68   
 Kinda Brave BRAVE Apr 25, 2025 0.94 -9.86   
 Kinnevik A KINVA Apr 25, 2025 79.80 -3.51   
 Kinnevik B KINVB Apr 25, 2025 74.36 -4.10   
 Kjell Group KJELL Apr 25, 2025 8.12 -4.47   
 KlaraBo KLARAB Apr 25, 2025 16.36 +0.12   
 Klaria Pharma Holding KLAR Apr 25, 2025 1.15 -3.77   
 Klimator KLIMAT Apr 25, 2025 2.32 +1.75   
 Knowit AB KNOW Apr 25, 2025 146.00 -0.41   
 Kontigo Care KONT Apr 25, 2025 2.38 +2.59   
 Kopparbergs B KOBRB Apr 25, 2025 115.40 -0.17   
 Krona Public Real Estate KRONA Apr 25, 2025 41.80 0.00   
 Kvix KVIX Apr 25, 2025 0.72 0.00   
 Lagercrantz Group B LAGRB Apr 25, 2025 214.00 +1.81   
 Lammhults Design Group B LAMMB Apr 25, 2025 35.41 +4.13   
 Latour B LATOB Apr 25, 2025 270.30 +0.93   
 Lea Bank LEA Apr 25, 2025 13.95 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.